Search Results
Department of Health Sciences, University of Florence, Florence, Italy
Search for other papers by Alessandro Barbato in
Google Scholar
PubMed
Search for other papers by Giulia Gori in
Google Scholar
PubMed
Search for other papers by Michele Sacchini in
Google Scholar
PubMed
Search for other papers by Francesca Pochiero in
Google Scholar
PubMed
Search for other papers by Sara Bargiacchi in
Google Scholar
PubMed
Search for other papers by Giovanna Traficante in
Google Scholar
PubMed
Search for other papers by Viviana Palazzo in
Google Scholar
PubMed
Search for other papers by Lucia Tiberi in
Google Scholar
PubMed
Search for other papers by Claudia Bianchini in
Google Scholar
PubMed
Search for other papers by Davide Mei in
Google Scholar
PubMed
Search for other papers by Elena Parrini in
Google Scholar
PubMed
Search for other papers by Tiziana Pisano in
Google Scholar
PubMed
Search for other papers by Elena Procopio in
Google Scholar
PubMed
NEUROFARBA Department, University of Florence, Florence, Italy
Search for other papers by Renzo Guerrini in
Google Scholar
PubMed
Department of Clinical and Experimental Biomedical Sciences “Mario Serio”, University of Florence, Florence, Italy
Search for other papers by Angela Peron in
Google Scholar
PubMed
Department of Health Sciences, University of Florence, Florence, Italy
Search for other papers by Stefano Stagi in
Google Scholar
PubMed
SCO1 ( 4 ). A further patient with MC4DN4, a girl described by Stiburek et al. ( 5 ) had left ventricular hypertrophy and a histological finding of an increased number of mitochondria, intrauterine growth restriction (IUGR), liver enlargement
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
School of Nursing and Midwifery, Institute of Clinical Sciences, University of Birmingham, UK
Search for other papers by Sherwin Criseno in
Google Scholar
PubMed
Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
Search for other papers by Helena Gleeson in
Google Scholar
PubMed
Search for other papers by Andrew A Toogood in
Google Scholar
PubMed
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
Search for other papers by Neil Gittoes in
Google Scholar
PubMed
Search for other papers by Anne Topping in
Google Scholar
PubMed
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
Search for other papers by Niki Karavitaki in
Google Scholar
PubMed
Introduction Growth hormone deficiency (GHD) is a clinical condition that can present in childhood or adult life. Adult-onset GHD is usually caused by a pituitary tumour and/or its treatments (surgery, radiotherapy) ( 1 ). Although the true
Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Mette Marie Baunsgaard in
Google Scholar
PubMed
Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Anne Sophie Lind Helligsoe in
Google Scholar
PubMed
Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Louise Tram Henriksen in
Google Scholar
PubMed
Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Torben Stamm Mikkelsen in
Google Scholar
PubMed
Search for other papers by Michael Callesen in
Google Scholar
PubMed
Search for other papers by Britta Weber in
Google Scholar
PubMed
Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Henrik Hasle in
Google Scholar
PubMed
Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark
Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Niels Birkebæk in
Google Scholar
PubMed
physical chronic late effects ( 15 ) with growth hormone deficiency (GHD) being the most common endocrinopathy ( 16 ) followed by thyroid-stimulating hormone deficiency ( 17 ). CR is the most significant risk factor for the development of GHD ( 18
Search for other papers by Xiaonan Guo in
Google Scholar
PubMed
Search for other papers by Wenjing Hu in
Google Scholar
PubMed
Search for other papers by Xiaorui Lyu in
Google Scholar
PubMed
Search for other papers by Hanyuan Xu in
Google Scholar
PubMed
Search for other papers by Huijuan Zhu in
Google Scholar
PubMed
Search for other papers by Hui Pan in
Google Scholar
PubMed
Search for other papers by Linjie Wang in
Google Scholar
PubMed
Search for other papers by Hongbo Yang in
Google Scholar
PubMed
Search for other papers by Fengying Gong in
Google Scholar
PubMed
Introduction Growth hormone (GH) is a significant regulator of growth and metabolism ( 1 ). In the liver, GH stimulates the synthesis and secretion of insulin-like growth factor 1 (IGF-1) ( 2 ). The GH/IGF-1 axis can regulate hepatic glucose
Search for other papers by Kevin C J Yuen in
Google Scholar
PubMed
Search for other papers by Gudmundur Johannsson in
Google Scholar
PubMed
Search for other papers by Ken K Y Ho in
Google Scholar
PubMed
Search for other papers by Bradley S Miller in
Google Scholar
PubMed
Search for other papers by Ignacio Bergada in
Google Scholar
PubMed
Search for other papers by Alan D Rogol in
Google Scholar
PubMed
Introduction Growth hormone deficiency (GHD) is a clinical syndrome that can present either as isolated GHD or associated with additional pituitary hormone deficiencies in children and adults. Childhood-onset GHD (CO-GHD) is often idiopathic
Search for other papers by Kirsten Davidse in
Google Scholar
PubMed
Search for other papers by Anneloes van Staa in
Google Scholar
PubMed
Search for other papers by Wanda Geilvoet in
Google Scholar
PubMed
Search for other papers by Judith P van Eck in
Google Scholar
PubMed
Search for other papers by Karlijn Pellikaan in
Google Scholar
PubMed
Search for other papers by Janneke Baan in
Google Scholar
PubMed
Academic Centre for Growth, Erasmus University Medical Centre, Rotterdam, the Netherlands
Dutch Growth Research Foundation, Rotterdam, the Netherlands
Search for other papers by Anita C S Hokken-Koelega in
Google Scholar
PubMed
Search for other papers by Erica L T van den Akker in
Google Scholar
PubMed
Diabeter, National Diabetes Care and Research Centre, Rotterdam, the Netherlands
Search for other papers by Theo Sas in
Google Scholar
PubMed
Department of Paediatrics, Leiden University Medical Centre, Leiden, the Netherlands
Search for other papers by Sabine E Hannema in
Google Scholar
PubMed
Search for other papers by Aart Jan van der Lely in
Google Scholar
PubMed
Academic Centre for Growth, Erasmus University Medical Centre, Rotterdam, the Netherlands
Search for other papers by Laura C G de Graaff in
Google Scholar
PubMed
%) did not need adult endocrine follow-up because paediatric endocrine care was only puberty- or growth-related. Of the 226 patients who had an indication for adult follow-up, 46 did not enter regular transition because they participated in a pilot to
Department of Infectious Diseases, Copenhagen University Hospital – Amager and Hvidovre, Hvidovre, Denmark
Search for other papers by Clara Lundetoft Clausen in
Google Scholar
PubMed
Search for other papers by Trine Holm Johannsen in
Google Scholar
PubMed
Search for other papers by Niels Erik Skakkebæk in
Google Scholar
PubMed
Search for other papers by Hanne Frederiksen in
Google Scholar
PubMed
Centre for Physical Activity Research, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
Search for other papers by Camilla Koch Ryrsø in
Google Scholar
PubMed
Search for other papers by Arnold Matovu Dungu in
Google Scholar
PubMed
Search for other papers by Maria Hein Hegelund in
Google Scholar
PubMed
Search for other papers by Daniel Faurholt-Jepsen in
Google Scholar
PubMed
Centre for Physical Activity Research, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
Search for other papers by Rikke Krogh-Madsen in
Google Scholar
PubMed
Centre for Physical Activity Research, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Birgitte Lindegaard in
Google Scholar
PubMed
Center for Clinical Research and Prevention, Copenhagen University Hospital – Bispebjerg and Frederiksberg, Copenhagen, Denmark
Search for other papers by Allan Linneberg in
Google Scholar
PubMed
Search for other papers by Line Lund Kårhus in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Anders Juul in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Thomas Benfield in
Google Scholar
PubMed
at the Department of Growth and Reproduction, Copenhagen University Hospital – Rigshospitalet. Hormones were tested once in all patients. Concentrations of testosterone and estrone sulfate were determined for all groups by isotope-dilution TurboFlow
Princess Máxima Center for Pediatric Oncology, AB Utrecht, The Netherlands
Search for other papers by Ichelle Maa van Roessel in
Google Scholar
PubMed
Princess Máxima Center for Pediatric Oncology, AB Utrecht, The Netherlands
Search for other papers by Boudewijn Bakker in
Google Scholar
PubMed
Princess Máxima Center for Pediatric Oncology, AB Utrecht, The Netherlands
Search for other papers by Hanneke M van Santen in
Google Scholar
PubMed
Search for other papers by Wassim Chemaitilly in
Google Scholar
PubMed
Introduction Endocrine disorders affect up to 60% of childhood cancer survivors (CCS) ( 1 ). Cancer, brain tumors and their treatments have been associated with a higher risk of deficiencies in growth hormone (GH), thyroid hormone and sex
Search for other papers by Stefan M Constantinescu in
Google Scholar
PubMed
Search for other papers by Thierry Duprez in
Google Scholar
PubMed
Search for other papers by Edward Fomekong in
Google Scholar
PubMed
Search for other papers by Christian Raftopoulos in
Google Scholar
PubMed
Search for other papers by Orsalia Alexopoulou in
Google Scholar
PubMed
Search for other papers by Dominique Maiter in
Google Scholar
PubMed
-related tumor growth, younger age, hormone or visual deficits, as well as unremitting headache are recognized indications for surgery, although they need to be discussed on a case by case basis by a specialized multidisciplinary pituitary team ( 6 ). When
Search for other papers by Jelena Stankovic in
Google Scholar
PubMed
Department of Pediatrics, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Kurt Kristensen in
Google Scholar
PubMed
Search for other papers by Niels Birkebæk in
Google Scholar
PubMed
Search for other papers by Jens Otto Lunde Jørgensen in
Google Scholar
PubMed
Steno Diabetes Center Aarhus (SDCA), Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Esben Søndergaard in
Google Scholar
PubMed
, which is commonly used for diagnosing growth hormone (GH) deficiency (GHD) in children ( 6 , 7 ), has proven valuable as a stimulant of the posterior pituitary too ( 1 ). Arginine-stimulated copeptin measurements is suggested as a safe and expedient